Thyroid disease mediated by molecular defects in cell surface and nuclear receptors - 09/09/11
Doi : 10.1016/S0002-9343(98)00319-2
Donald L. Bodenner, MD, PhD a, ⁎, Robert W. Lash, MD b
a Department of Internal Medicine (DLB), Division of Endocrinology and Metabolism, Little Rock, Arkansas, USA
b Department of Internal Medicine (RWL), Division of Endocrinology and Metabolism, University of Michigan Health System, Ann Arbor, Michigan, USA
*Requests for reprints should be addressed to Dr. Donald L. Bodenner, Department of Internal Medicine, Division of Endocrinology and Metabolism, 4301 West Markham, Little Rock, Arkansas 72205
Vol 105 - N° 6
P. 524-538 - décembre 1998 Retour au numéro
Article précédent
- Risk reduction in the intensive care unit
- Sanjay Saint, Michael A. Matthay
- Reciprocal changes in progression of gastric mucosa-associated lymphoid tissue lymphoma and pancreatic somatostatinoma
- Toru Maekawa, Yoshikazu Kinoshita, Hirokazu Fukui, Shigemi Matsumoto, Syozo Hirota, Kazuo Chihara, Takahiro Fujimori, Tsutomu Chiba
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?